Aucubin inhibits the activity of lung cancer stem-like cells by targeting degradation of β -catenin
Journal of Pharmacy and Pharmacology · 2025
DOI: 10.1093/jpp/rgaf081 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy and Pharmacology, 2025. Verfasst von Qian Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, Hebei Medical University Third Hospital. No. 139 Ziqiang Road, Qiaoxi District, Shijiazhuang 050051, China. Hauptthemen laut MEDLINE: Lung Neoplasms, beta Catenin, Neoplastic Stem Cells, Carcinoma, Non-Small-Cell Lung. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Objectives
To investigate the antitumor effects of aucubin (AC) in non-small cell lung cancer (NSCLC) and uncover its plausible mechanism against lung cancer stem-like cells (LCSCs).
Methods
In vitro experiments included MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide, a reagent commonly used for cell viability assay) and colony formation assays to assess anti-proliferative effects on A549 and NCI-H1975 lung cancer cell lines, wound healing and Transwell invasion assays to evaluate inhibition of cell migration and invasion, tumorsphere-formation experiments to detect changes in NSCLC cell stemness, as well as Western blot and quantitative reverse transcription polymerase chain reaction (qRT-PCR) analyses to measure the expression of LCSC markers (CD44, CD133, Oct4, and Nanog). In vivo experiments were conducted to observe the impact of AC on NSCLC metastasis and mouse survival rates. Further mechanistic studies involved transcriptomic gene set enrichment analysis, Western blot, qRT-PCR, molecular docking, and Surface Plasmon Resonance (SPR) methods to investigate how AC directly targets β-catenin and promotes its ubiquitin-mediated degradation. Key findings AC exerted significant anti-proliferative effects on A549 and NCI-H1975 cells, inhibited cancer cell migration and invasion, reduced the stemness of NSCLC cells, and markedly downregulated the expression of LCSC markers in vitro. In vivo, AC treatment significantly reduced NSCLC metastasis and improved mouse survival rates. Mechanistically, AC blocked the WNT (Wingless-related integration site, a family of secreted lipid-modified signaling glycoproteins that play crucial roles in embryonic development, tissue homeostasis, and regeneration) signaling pathway by downregulating β-catenin and c-Myc expression. It directly targeted β-catenin, promoting its degradation via the ubiquitin-proteasome pathway.
Conclusions
This study uncovers a novel anti-LCSC mechanism of AC, offers alternative strategies for NSCLC treatment, and provides innovative lead compounds for the development of drugs targeting lung cancer stem cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Pharmacy, Hebei Medical University Third Hospital. No. 139 Ziqiang Road, Qiaoxi District, Shijiazhuang 050051, China.
ORCID-Profile: Qian Li
Zitieren
APA
Li, Q., Xie, H., Li, L., Yan, W., & Liu, G. (2025). Aucubin inhibits the activity of lung cancer stem-like cells by targeting degradation of β -catenin. Journal of Pharmacy and Pharmacology. https://doi.org/10.1093/jpp/rgaf081
Vancouver
Li Q, Xie H, Li L, Yan W, Liu G. Aucubin inhibits the activity of lung cancer stem-like cells by targeting degradation of β -catenin. Journal of Pharmacy and Pharmacology. 2025. doi:10.1093/jpp/rgaf081
BibTeX
@article{Li2025,
author = {Li, Qian and Xie, Hao and Li, Linli and Yan, Wenying and Liu, Guoqiang},
title = {Aucubin inhibits the activity of lung cancer stem-like cells by targeting degradation of β -catenin},
journal = {Journal of Pharmacy and Pharmacology},
year = {2025},
doi = {10.1093/jpp/rgaf081}
}
EUVIMED